RETRACTION: Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer

被引：0
|
作者：
Pan, Hongda [1 ,2 ,3 ,4 ]
Pan, Jingxin [2 ]
Ji, Lei [3 ]
Song, Shibo [4 ]
Lv, Hong [3 ]
Yang, Zhangru [3 ]
Guo, Yibin [5 ]
机构：
[1] Fudan Univ, Dept Gastr Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 2, Quanzhou 362000, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[4] Beijing Hosp, Dept Gastrointestinal Surg, Beijing 100730, Peoples R China
[5] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Med Genet, Guangzhou 510080, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2025年 / 293卷
关键词：
D O I：
10.1016/j.ijbiomac.2024.138909
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer
    Pan, Hongda
    Pan, Jingxin
    Ji, Lei
    Song, Shibo
    Lv, Hong
    Yang, Zhangru
    Guo, Yibin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 138 : 125 - 134
  • [2] The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
    Tian, Xin-Yuan
    Li, Jin
    Liu, Teng-Hui
    Li, Dan-Ni
    Wang, Jing-Jing
    Zhang, He
    Deng, Zhou-Lu
    Chen, Fu-Jun
    Cai, Jian-Ping
    CANCER MEDICINE, 2020, 9 (22): : 8612 - 8623
  • [3] Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
    Tong, Xiaoguang
    Barbour, Mark
    Hou, Kezuo
    Gao, Chao
    Cao, Shuang
    Zheng, Jingli
    Zhao, Yang
    Mu, Rong
    Jiang, Hui-Rong
    MOLECULAR ONCOLOGY, 2016, 10 (01) : 113 - 125
  • [4] RPS9 promotes the progression of NSCLC via activation Stat3 and Erk signaling pathways
    Kong, Yiru
    Deng Shuangshuang
    Liang, Xiaohua
    Zhou, Xinli
    JOURNAL OF CANCER, 2022, 13 (04): : 1346 - 1355
  • [5] HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis
    Li, X.
    Zhang, N-X
    Ye, H-Y
    Song, P-P
    Chang, W.
    Chen, L.
    Wang, Z.
    Zhang, L.
    Wang, N-N
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (10) : 4126 - 4135
  • [6] PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
    Yu, Wendan
    Hua, Yijun
    Qiu, Huijuan
    Hao, Jiaojiao
    Zou, Kun
    Li, Zongjuan
    Hu, Sheng
    Guo, Ping
    Chen, Manyu
    Sui, Silei
    Xiong, Yuqing
    Li, Fengzhou
    Lu, Jianjun
    Guo, Wei
    Luo, Guangyu
    Deng, Wuguo
    CELL DEATH & DISEASE, 2020, 11 (07)
  • [7] PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
    Wendan Yu
    Yijun Hua
    Huijuan Qiu
    Jiaojiao Hao
    Kun Zou
    Zongjuan Li
    Sheng Hu
    Ping Guo
    Manyu Chen
    Silei Sui
    Yuqing Xiong
    Fengzhou Li
    Jianjun Lu
    Wei Guo
    Guangyu Luo
    Wuguo Deng
    Cell Death & Disease, 11
  • [8] TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling
    Shengli Pan
    Yingying Deng
    Jun Fu
    Yuhao Zhang
    Zhijin Zhang
    Xiaokun Ru
    Xianju Qin
    Cancer Cell International, 19
  • [9] TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling
    Pan, Shengli
    Deng, Yingying
    Fu, Jun
    Zhang, Yuhao
    Zhang, Zhijin
    Ru, Xiaokun
    Qin, Xianju
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [10] Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling
    Hu, Kebang
    Tian, Yong
    Du, Yanwei
    Huang, Liandi
    Chen, Junyu
    Li, Na
    Liu, Wei
    Liang, Zuowen
    Zhao, Lijing
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (05) : 2166 - 2174
12345